Amedica's ceramic spinal implant:
This article was originally published in Clinica
Orthopaedics firm Amedica has been granted a special 510(k) marketing clearance by the US FDA for its Valeo ceramic vertebral body replacement (VBR) spinal implant. The device is intended to aid in surgical stabilisation of the thoracolumbar spine. The Valeo VBR incorporates the Salt Lake City, Utah company's novel silicon nitride ceramic, which provides functionalities that are not available in devices currently on the market. The implant should restore the biomechanical integrity of the anterior, middle and posterior spine, even in the absence of fusion, for a prolonged period of time, said the company.
You may also be interested in...
Pharma manufacturing is operating well below normal levels in India, disrupted by labor absenteeism and supply chain issues amid the ongoing lock-down in the country, though the government is actively engaged in addressing bottlenecks. A speedy recovery is vital not just for domestic supplies.
Moderna is pursuing a single-antigen strategy even though some of its mRNA vaccines have included multiple antigens; the SARS-CoV-2 spike protein likely provides the best antigen for developing immunity against the virus.
Latest warnings also include second and third businesses in US cannabidiol and hemp sector found making unlawful claims for treating and preventing COVID-19. Four of five firms warned apparently responded by removing violative claims from websites and social media posts.